Helicos BioSciences (HLCS) Names Lowy as CEO
Helicos BioSciences (NASDAQ: HLCS) announced today that its Board of Directors has appointed Ronald Lowy as the company's CEO, effective immediately.
Helicos BioSciences Corporation, a life sciences company, engages in the development of genetic analysis technologies for the research, drug discovery, and clinical diagnostics markets.
Create E-mail AlertRelated Categories
Management ChangesStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
